Cargando…

Potential health risks of complementary alternative medicines in cancer patients

Many cancer patients use complementary alternative medicines (CAMs) but may not be aware of the potential risks. There are no studies quantifying such risks, but there is some evidence of patient risk from case reports in the literature. A cross-sectional survey of patients attending the outpatient...

Descripción completa

Detalles Bibliográficos
Autores principales: Werneke, U, Earl, J, Seydel, C, Horn, O, Crichton, P, Fannon, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410154/
https://www.ncbi.nlm.nih.gov/pubmed/14735185
http://dx.doi.org/10.1038/sj.bjc.6601560
_version_ 1782155939749560320
author Werneke, U
Earl, J
Seydel, C
Horn, O
Crichton, P
Fannon, D
author_facet Werneke, U
Earl, J
Seydel, C
Horn, O
Crichton, P
Fannon, D
author_sort Werneke, U
collection PubMed
description Many cancer patients use complementary alternative medicines (CAMs) but may not be aware of the potential risks. There are no studies quantifying such risks, but there is some evidence of patient risk from case reports in the literature. A cross-sectional survey of patients attending the outpatient department at a specialist cancer centre was carried out to establish a pattern of herbal remedy or supplement use and to identify potential adverse side effects or drug interactions with conventional medicines. If potential risks were identified, a health warning was issued by a pharmacist. A total of 318 patients participated in the study. Of these, 164 (51.6%) took CAMs, and 133 different combinations were recorded. Of these, 10.4% only took herbal remedies, 42.1% only supplements and 47.6% a combination of both. In all, 18 (11.0%) reported supplements in higher than recommended doses. Health warnings were issued to 20 (12.2%) patients. Most warnings concerned echinacea in patients with lymphoma. Further warnings were issued for cod liver/fish oil, evening primrose oil, gingko, garlic, ginseng, kava kava and beta-carotene. In conclusion, medical practitioners need to be able to identify the potential risks of CAMs. Equally, patients should be encouraged to disclose their use. Also, more research is needed to quantify the actual health risks.
format Text
id pubmed-2410154
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24101542009-09-10 Potential health risks of complementary alternative medicines in cancer patients Werneke, U Earl, J Seydel, C Horn, O Crichton, P Fannon, D Br J Cancer Clinical Many cancer patients use complementary alternative medicines (CAMs) but may not be aware of the potential risks. There are no studies quantifying such risks, but there is some evidence of patient risk from case reports in the literature. A cross-sectional survey of patients attending the outpatient department at a specialist cancer centre was carried out to establish a pattern of herbal remedy or supplement use and to identify potential adverse side effects or drug interactions with conventional medicines. If potential risks were identified, a health warning was issued by a pharmacist. A total of 318 patients participated in the study. Of these, 164 (51.6%) took CAMs, and 133 different combinations were recorded. Of these, 10.4% only took herbal remedies, 42.1% only supplements and 47.6% a combination of both. In all, 18 (11.0%) reported supplements in higher than recommended doses. Health warnings were issued to 20 (12.2%) patients. Most warnings concerned echinacea in patients with lymphoma. Further warnings were issued for cod liver/fish oil, evening primrose oil, gingko, garlic, ginseng, kava kava and beta-carotene. In conclusion, medical practitioners need to be able to identify the potential risks of CAMs. Equally, patients should be encouraged to disclose their use. Also, more research is needed to quantify the actual health risks. Nature Publishing Group 2004-01-26 2004-01-20 /pmc/articles/PMC2410154/ /pubmed/14735185 http://dx.doi.org/10.1038/sj.bjc.6601560 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical
Werneke, U
Earl, J
Seydel, C
Horn, O
Crichton, P
Fannon, D
Potential health risks of complementary alternative medicines in cancer patients
title Potential health risks of complementary alternative medicines in cancer patients
title_full Potential health risks of complementary alternative medicines in cancer patients
title_fullStr Potential health risks of complementary alternative medicines in cancer patients
title_full_unstemmed Potential health risks of complementary alternative medicines in cancer patients
title_short Potential health risks of complementary alternative medicines in cancer patients
title_sort potential health risks of complementary alternative medicines in cancer patients
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410154/
https://www.ncbi.nlm.nih.gov/pubmed/14735185
http://dx.doi.org/10.1038/sj.bjc.6601560
work_keys_str_mv AT wernekeu potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients
AT earlj potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients
AT seydelc potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients
AT horno potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients
AT crichtonp potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients
AT fannond potentialhealthrisksofcomplementaryalternativemedicinesincancerpatients